CHRISTINA RYDER: Open Payments
NPI 1841955465 · COLLEGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,496 in 130 payments from 14 companies in 2025. Trend: 2023 $2,011 · 2024 $2,097 · 2025 $2,496
Food & beverage: $2,391Education: $104
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $384 |
| Vanda Pharmaceuticals Inc. | 16 | $305 |
| Otsuka America Pharmaceutical, Inc. | 13 | $222 |
| Janssen Pharmaceuticals, Inc | 9 | $201 |
| Teva Pharmaceuticals USA, Inc. | 6 | $192 |
| Collegium Pharmaceutical, Inc. | 8 | $148 |
| Supernus Pharmaceuticals, Inc. | 13 | $145 |
| ABBVIE INC. | 17 | $145 |
| Axsome Therapeutics, Inc. | 5 | $120 |
Products named: INGREZZA, CAPLYTA, FANAPT, REXULTI, INVEGA SUSTENNA, Jornay PM, Qelbree, VRAYLAR.
Industry payments across PA — which companies pay providers there.
